Efficacy and safety of once‐weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52‐week open‐label, randomized phase III trial

AIM: To compare the efficacy and safety of once‐weekly dulaglutide with that of insulin glargine in combination with metformin and/or a sulphonylurea in mainly Asian patients with type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: In this 52‐week, randomized, parallel‐arm open‐label study, we e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Weiqing, Nevárez, Luis, Filippova, Ekaterina, Song, Ki Ho, Tao, Bei, Gu, Liqun, Wang, Feng, Li, Pengfei, Yang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585712/
https://www.ncbi.nlm.nih.gov/pubmed/30129089
http://dx.doi.org/10.1111/dom.13506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585712/
https://www.ncbi.nlm.nih.gov/pubmed/30129089
http://dx.doi.org/10.1111/dom.13506

Ejemplares similares